Does iron accumulation in the brain contribute to neurodegeneration?
Peer-Reviewed Publication
This month, we’re spotlighting Parkinson’s disease research in recognition of Parkinson’s Awareness Month. Here, we’ll share the latest research on Parkinson’s disease, how scientists are working to better understand its causes and progression, advances in treatment and care, and more.
Updates every hour. Last Updated: 20-Oct-2026 12:17 ET (20-Oct-2026 16:17 GMT/UTC)
Salk scientists explore long-standing mystery of why iron that builds up in neuronal cells becomes harmful over time in neurodegenerative diseases like Alzheimer’s and Parkinson’s, finding a new cellular process, named chronoferroptosis, wherein chronic iron dysregulation in neurons makes them more vulnerable to stressors. The study complements other ongoing research at Salk to design compounds that inhibit this pathway, and could be a promising future avenue for creating therapies that boost resilience in aging brains.
What happens when evolution rewires a brain for life in total darkness? In a study of the blind Mexican cavefish, researchers uncovered an evolutionary surprise: unlike their sighted relatives, cavefish become more active in light rather than darkness. Using whole-brain imaging at cellular resolution, the team revealed that neural circuits have effectively flipped their responses to light and dark. The findings offer a rare glimpse into how evolution reshapes the brain and could shed light on neurological disorders ranging from Parkinson’s disease to autism and ADHD.
UC San Francisco researchers have developed a new form of deep brain stimulation (DBS) that adjusts in real time as a person walks, helping improve gait and reduce falls in people with Parkinson’s disease. The study, publishing June 15 in Nature Medicine, demonstrates for the first time that an implanted brain stimulator can detect neural signals associated with each step and automatically adjust stimulation within fractions of a second.
EPFL and CHUV researchers have developed the first AI-assisted, real-time deep-brain stimulation therapy for walking impairments in Parkinson’s disease.